ALK-POSITIVE LUNG CANCER

Clinical trials for ALK-POSITIVE LUNG CANCER explained in plain language.

Never miss a new study

Get alerted when new ALK-POSITIVE LUNG CANCER trials appear

Sign up with your email to follow new studies for ALK-POSITIVE LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New pill targets Tough-to-Treat lung cancer in groundbreaking trial

Disease control Recruiting now

This study is testing a new oral medication called TRI-611 for adults with advanced ALK-positive non-small cell lung cancer. The first part aims to find a safe and effective dose, while the second part will see how well the drug works in different groups of patients based on thei…

Matched conditions: ALK-POSITIVE LUNG CANCER

Phase: PHASE1, PHASE2 • Sponsor: TRIANA Biomedicines, Inc. • Aim: Disease control

Last updated Apr 03, 2026 14:41 UTC

ALK-POSITIVE LUNG CANCER

Get alerted when new ALK-POSITIVE LUNG CANCER trials appear

New pill targets Tough-to-Treat lung cancer in groundbreaking trial